Continuous Tralokinumab Treatment over 4 Years in Adults with Moderate-to-Severe Atopic Dermatitis Provides Long-Term Disease Control. J of Skin [Internet]. 2024 Mar. 18 [cited 2026 Apr. 18];8(2):s376. Available from: https://skin.dermsquared.com/skin/article/view/2679